Lymphocyte Trafficking in Tumor Microcirculation
Author Information
Author(s): NJ Brown, S Ali, MWR Reed, R Wiltrout, RC Rees
Primary Institution: University of Sheffield
Hypothesis
The study aims to establish a model of tumor microcirculation in vivo and investigate the trafficking of lymphocyte subpopulations into the RENCA tumor and surrounding normal microcirculation.
Conclusion
IL-2-activated lymphocytes show selective adhesion to the RENCA tumor microcirculation, indicating their potential for targeted cancer therapy.
Supporting Evidence
- IL-2-activated splenocytes were selectively recruited to the tumor microcirculation.
- Naive splenocytes and T-cell enriched populations did not adhere to the tumor endothelium.
- Fluorescently labeled effector cells were visualized moving through both tumor and normal microcirculation.
Takeaway
The study shows that special immune cells can find and stick to cancer cells better when they are activated, which could help in treating tumors.
Methodology
The study used in vivo microscopy to visualize the trafficking of fluorescently labeled lymphocytes in a mouse model with implanted RENCA tumor cells.
Limitations
The study may not fully represent human tumor behavior due to the use of a murine model.
Participant Demographics
6-week-old Balb/c mice weighing 15 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website